Aerie Pharmaceuticals PEG Ratio

The latest PEG ratio for AERI is 29.22. That is above the Healthcare sector average of -5.81. Investors often review this figure alongside Aerie Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, AERI currently prints 29.22 for PEG ratio, while the sector average sits near -5.81. That is roughly 603.0% above the sector mean. Large gaps often invite a closer look at Aerie Pharmaceuticals's growth, margins, and balance sheet.

A PEG ratio of 29.22 for Aerie Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (-5.81) and with AERI's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting AERI's PEG ratio (29.22), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Aerie Pharmaceuticals's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.